Trial intelligence / Profile preview

Isotretinoin for Sperm Production in Oligozoospermia

NCT06698263Phase 4Not yet recruiting

Sponsor
Strasbourg University Hospital
Start
Mar 2025
Primary completion
Dec 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of isotretinoin in oligozoospermia, sponsored by Strasbourg University Hospital. Planned start Mar 2025; status: not yet recruiting.

02

Drugs

isotretinoin
03

Conditions

oligozoospermia

Beyond the preview

Go deeper on NCT06698263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06698263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call